Skip to main content
SpringerLink
Log in

SCS in PDPN not cost effective in the short term

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The study was supported by Medtronic.

Reference

  • Slangen R, et al. A trial based economic evaluation comparing spinal cord stimulation with best medical treatment in painful diabetic peripheral neuropathy. Journal of Pain : 11 Dec 2016. Available from: URL: http://doi.org/10.1016/j.jpain.2016.11.014

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

SCS in PDPN not cost effective in the short term. PharmacoEcon Outcomes News 769, 27 (2017). https://doi.org/10.1007/s40274-017-3663-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3663-y

Search

Navigation